Funding Postauthorization Vaccine-Safety Science-Reference-Cited by-同舟云学术

Funding Postauthorization Vaccine-Safety Science

Published:2024-07-11 Issue:2 Volume:391 Page:102-105
ISSN:0028-4793
Container-title:New England Journal of Medicine
language:en
Short-container-title:N Engl J Med

Author:

Salmon Daniel A.¹,Orenstein Walter A.¹,Plotkin Stanley A.¹,Chen Robert T.¹

Affiliation:

1. From the Institute for Vaccine Safety, Johns Hopkins Bloomberg School of Public Health, Baltimore (D.A.S.); Emory University, Atlanta (W.O.); the University of Pennsylvania, Philadelphia (S.A.P.); and the Brighton Collaboration, Task Force for Global Health, Decatur, GA (R.T.C.).

Publisher

Massachusetts Medical Society

Link

http://www.nejm.org/doi/pdf/10.1056/NEJMp2402379

Reference5 articles.

1. Lessons learned from COVID-19, H1N1, and routine vaccine pharmacovigilance in the United States: a path to a more robust vaccine safety program

2. The Advisory Committee on Immunization Practices’ Interim Recommendation for Use of Pfizer-BioNTech COVID-19 Vaccine — United States, December 2020

3. Advancing the Science of Vaccine Safety During the Coronavirus Disease 2019 (COVID-19) Pandemic and Beyond: Launching an International Network of Special Immunization Services

4. United States Senate. National Childhood Vaccine-Injury Compensation Act Hearing (S2117). Committee on Labor and Human Resources. 98th Congress; Second Session. Washington DC: U.S. Government Printing Office; May 3 1984 (https://files.eric.ed.gov/fulltext/ED255480.pdf).

5. National Childhood Vaccine Improvement Act of 1986 S. Rep. no. 483 99th Cong. 2d Sess. (1985-1986).

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Improving trustworthiness in global health;The Lancet;2024-09